Copyright
©The Author(s) 2019.
World J Clin Oncol. Sep 24, 2019; 10(9): 300-302
Published online Sep 24, 2019. doi: 10.5306/wjco.v10.i9.300
Published online Sep 24, 2019. doi: 10.5306/wjco.v10.i9.300
Gangliocytic paraganglioma | Gastrointestinal neuroendocrine tumor G1 | |
Predominant site of the primary tumor | Duodenum (approximately 90%) | Small intestine, but duodenal is relatively rare |
5-yr survival rates | Excellent (approximately 100%) | Good (approximately 80%) |
Incidence | Extremely rare | Relatively rare, but gradually increasing, incidence worldwide |
Morphological findings obtained by surgery | Epithelioid, spindle, and ganglion-like cells | Nesting, trabecular pattern, and/or rosette formation with nuclear palisading |
Immunohistochemistry (pancreatic polypeptide and progesterone receptor) | Epithelioid cells show positive reactivity for both. | Tumor cells show negative reactivity for both |
Perspective | Accurate diagnosis of gangliocytic paraganglioma will facilitate the use of less invasive treatment procedures |
- Citation: Okubo Y. Gangliocytic paraganglioma: An overview and future perspective. World J Clin Oncol 2019; 10(9): 300-302
- URL: https://www.wjgnet.com/2218-4333/full/v10/i9/300.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i9.300